PSORIASIS
Clinical trials for PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS trials appear
Sign up with your email to follow new studies for PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Psoriasis combo therapy put to the test: methotrexate plus biologic
Disease control TerminatedThis study looked at whether adding low-dose methotrexate to standard anti-TNF treatment helps adults with moderate to severe psoriasis maintain improvement longer. About 78 participants were randomly assigned to receive either methotrexate or a placebo alongside their anti-TNF m…
Matched conditions: PSORIASIS
Phase: PHASE4 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New drug for skin conditions tested in small study
Symptom relief TerminatedThis study tested a new drug called XmAb27564 in 23 people with plaque psoriasis or atopic dermatitis (eczema). The main goal was to see if the drug is safe and tolerable when given as multiple injections. The trial was stopped early, and results are not yet available.
Matched conditions: PSORIASIS
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Symptom relief
Last updated May 17, 2026 00:26 UTC
-
Insulin's hidden role in psoriasis revealed?
Knowledge-focused TerminatedThis study aimed to understand if insulin works differently in psoriasis skin patches compared to healthy skin. Researchers took small skin samples from 10 people with plaque psoriasis before and after a sugar drink. The study was stopped early, so results are limited.
Matched conditions: PSORIASIS
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC